179 related articles for article (PubMed ID: 22728465)
1. Free hemoglobin induction of pulmonary vascular disease: evidence for an inflammatory mechanism.
Buehler PW; Baek JH; Lisk C; Connor I; Sullivan T; Kominsky D; Majka S; Stenmark KR; Nozik-Grayck E; Bonaventura J; Irwin DC
Am J Physiol Lung Cell Mol Physiol; 2012 Aug; 303(4):L312-26. PubMed ID: 22728465
[TBL] [Abstract][Full Text] [Related]
2. Hemoglobin-induced lung vascular oxidation, inflammation, and remodeling contribute to the progression of hypoxic pulmonary hypertension and is attenuated in rats with repeated-dose haptoglobin administration.
Irwin DC; Baek JH; Hassell K; Nuss R; Eigenberger P; Lisk C; Loomis Z; Maltzahn J; Stenmark KR; Nozik-Grayck E; Buehler PW
Free Radic Biol Med; 2015 May; 82():50-62. PubMed ID: 25656991
[TBL] [Abstract][Full Text] [Related]
3. Contribution of xanthine oxidase-derived superoxide to chronic hypoxic pulmonary hypertension in neonatal rats.
Jankov RP; Kantores C; Pan J; Belik J
Am J Physiol Lung Cell Mol Physiol; 2008 Feb; 294(2):L233-45. PubMed ID: 18083771
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat.
DeMarco VG; Habibi J; Whaley-Connell AT; Schneider RI; Heller RL; Bosanquet JP; Hayden MR; Delcour K; Cooper SA; Andresen BT; Sowers JR; Dellsperger KC
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2659-68. PubMed ID: 18424632
[TBL] [Abstract][Full Text] [Related]
5. Long-acting phosphodiesterase 5 inhibitor, tadalafil, and superoxide dismutase mimetic, tempol, protect against acute hypoxia-induced pulmonary hypertension in rats.
Rashid M; Kotwani A; Fahim M
Hum Exp Toxicol; 2012 Jun; 31(6):626-36. PubMed ID: 22144729
[TBL] [Abstract][Full Text] [Related]
6. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
[TBL] [Abstract][Full Text] [Related]
7. Iptakalim attenuates hypoxia-induced pulmonary arterial hypertension in rats by endothelial function protection.
Zhu R; Bi LQ; Wu SL; Li L; Kong H; Xie WP; Wang H; Meng ZL
Mol Med Rep; 2015 Aug; 12(2):2945-52. PubMed ID: 25936382
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of tadalafil in chronic hypobaric hypoxia-induced pulmonary hypertension: possible mechanisms.
Rashid M; Fahim M; Kotwani A
Fundam Clin Pharmacol; 2013 Jun; 27(3):271-8. PubMed ID: 22251079
[TBL] [Abstract][Full Text] [Related]
9. Melatonin Attenuates Pulmonary Hypertension in Chronically Hypoxic Rats.
Hung MW; Yeung HM; Lau CF; Poon AMS; Tipoe GL; Fung ML
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28538666
[TBL] [Abstract][Full Text] [Related]
10. Tempol-nebivolol therapy potentiates hypotensive effect increasing NO bioavailability and signaling pathway.
Bertera FM; Santa-Cruz DM; Balestrasse KB; Gorzalczany SB; Höcht C; Taira CA; Polizio AH
Free Radic Res; 2014 Feb; 48(2):109-18. PubMed ID: 24074298
[TBL] [Abstract][Full Text] [Related]
11. Hemoglobin infusion does not alter murine pulmonary vascular tone.
Beloiartsev A; Baron DM; Yu B; Bloch KD; Zapol WM
Nitric Oxide; 2013 Apr; 30():1-8. PubMed ID: 23313572
[TBL] [Abstract][Full Text] [Related]
12. Contribution of reactive oxygen species to the pathogenesis of pulmonary arterial hypertension.
Jernigan NL; Naik JS; Weise-Cross L; Detweiler ND; Herbert LM; Yellowhair TR; Resta TC
PLoS One; 2017; 12(6):e0180455. PubMed ID: 28666030
[TBL] [Abstract][Full Text] [Related]
13. Intermedin modulates hypoxic pulmonary vascular remodeling by inhibiting pulmonary artery smooth muscle cell proliferation.
Mao SZ; Fan XF; Xue F; Chen R; Chen XY; Yuan GS; Hu LG; Liu SF; Gong YS
Pulm Pharmacol Ther; 2014 Feb; 27(1):1-9. PubMed ID: 23796770
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide inhalation decreases pulmonary artery remodeling in the injured lungs of rat pups.
Roberts JD; Chiche JD; Weimann J; Steudel W; Zapol WM; Bloch KD
Circ Res; 2000 Jul; 87(2):140-5. PubMed ID: 10903998
[TBL] [Abstract][Full Text] [Related]
15. Novel peptide for attenuation of hypoxia-induced pulmonary hypertension via modulation of nitric oxide release and phosphodiesterase -5 activity.
Hu H; Zharikov S; Patel JM
Peptides; 2012 May; 35(1):78-85. PubMed ID: 22465621
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress mediates renal endothelial cell damage in trichloroethylene-sensitized mice.
Li B; Xie H; Wang X; Yang X; Yang L; Zhang J; Wang F; Shen T; Zhu Q
J Toxicol Sci; 2019; 44(5):317-326. PubMed ID: 31068537
[TBL] [Abstract][Full Text] [Related]
17. Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension.
Kang Y; Zhang G; Huang EC; Huang J; Cai J; Cai L; Wang S; Keller BB
Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H853-H866. PubMed ID: 32108526
[TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin ameliorates the development of pulmonary arterial hypertension in the transgenic (mRen2)27 rat.
DeMarco VG; Habibi J; Whaley-Connell AT; Schneider RI; Sowers JR; Andresen BT; Gutweiler AA; Ma L; Johnson MS; Ferrario CM; Dellsperger KC
Am J Physiol Heart Circ Physiol; 2009 Sep; 297(3):H1128-39. PubMed ID: 19633211
[TBL] [Abstract][Full Text] [Related]
19. L-arginine or tempol supplementation improves renal and cardiovascular function in rats with reduced renal mass and chronic high salt intake.
Carlström M; Brown RD; Yang T; Hezel M; Larsson E; Scheffer PG; Teerlink T; Lundberg JO; Persson AE
Acta Physiol (Oxf); 2013 Apr; 207(4):732-41. PubMed ID: 23387940
[TBL] [Abstract][Full Text] [Related]
20. The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension.
Fan YF; Zhang R; Jiang X; Wen L; Wu DC; Liu D; Yuan P; Wang YL; Jing ZC
Cardiovasc Res; 2013 Aug; 99(3):395-403. PubMed ID: 23650288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
